Piedmont Investment Advisors’s Integra LifeSciences IART Stock Holding History

Piedmont Investment Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,392	Closed	-$241K	–	325
2020 Q1	$241K	Hold	5,392	–	–	0.01%	675
2019 Q4	$314K	Sell	5,392 -948	-15%	-$56.4K	0.01%	734
2019 Q3	$381K	Sell	6,340 -500	-7%	-$29.8K	0.01%	640
2019 Q2	$382K	Buy	6,840 +969	+17%	+$49.9K	0.02%	663
2019 Q1	$327K	Buy	5,871 +27	+0.5%	+$1.38K	0.01%	762
2018 Q4	$264K	Buy	5,844 +1,871	+47%	+$103K	0.01%	798
2018 Q3	$262K	Buy	3,973 +3,967	+66,117%	+$247K	0.01%	845
2018 Q2	$0	Sell	6 -13,581	-100%	-$841K	﹤0.01%	2887
2018 Q1	$752K	Buy	13,587 +522	+4%	+$27.4K	0.02%	339
2017 Q4	$625K	Sell	13,065 -712	-5%	-$34.9K	0.01%	365
2017 Q3	$695K	Buy	13,777 +696	+5%	+$35.7K	0.01%	349
2017 Q2	$713K	Buy	+13,081	New	+$625K	0.02%	347

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Piedmont Investment Advisors's IART Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Integra LifeSciences (IART) in Q2 2020, closing a stake of 5,392 shares — an estimated $241K sold.

Piedmont Investment Advisors first reported a position in IART in Q2 2017 and held it in 12 quarters. The position peaked at $752K in Q1 2018. 264 funds tracked by Wall St. Rank hold IART as of Q2 2020.

Piedmont Investment Advisors reported no remaining Integra LifeSciences position as of Q2 2020 after selling out during the quarter.
Piedmont Investment Advisors sold 5,392 Integra LifeSciences shares in Q2 2020, an estimated $241K.
Piedmont Investment Advisors first reported a position in Integra LifeSciences in Q2 2017 and held it in 12 quarters.
Piedmont Investment Advisors's Integra LifeSciences position peaked at $752K in Q1 2018.
264 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.